Detalhe da pesquisa
1.
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Clin Gastroenterol Hepatol
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492903
2.
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Clin Gastroenterol Hepatol
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492904
3.
Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
Rheumatol Ther
; 11(1): 97-112, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982966
4.
Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States.
ACR Open Rheumatol
; 6(4): 179-188, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38221639
5.
Detection of HIV-1 and Human Proteins in Urinary Extracellular Vesicles from HIV+ Patients.
Adv Virol
; 2018: 7863412, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721020